Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

72.24 9.20 −11.30%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a

Globus Medical, Inc. (GMED) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Globus Medical, Inc. (GMED) trades at a EV/FCF of 14.9×. Over the past ten years it has ranged from 13.5× (October 2026) to 72.4× (February 2023); the current reading is higher than 3% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 21.3× (22.98%)
FY2024 27.6× (22.94%)
FY2023 35.9× (45.81%)
FY2022 66.2× 112.38%
FY2021 31.2× (29.92%)
FY2020 44.5× (18.60%)
FY2019 54.6× 77.92%
FY2018 30.7× (12.52%)
FY2017 35.1× 80.34%
FY2016 19.5× (39.02%)

Quarterly newest first

Period EV/FCF Change
Sep 2026 13.8× (7.08%)
Jun 2026 14.9× (26.20%)
Mar 2026 20.1× (5.36%)
Dec 2025 21.3× 45.79%
43 more quarters

Against its own ten years

Low 13.5× High 72.4×
Ten-year median 37.0×
Current reading's percentile 3

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on GMED